乙基(5-氯-2-噻吩基)(氧代)乙酸酯 | 34036-28-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 乙基(5-氯-2-噻吩基)(氧代)乙酸酯
• 英文名称: ethyl (5-chloro-2-thienyl)glyoxylate
• 英文别名: 2-Chlor-5-ethoxyoxalyl-thiophen；(5-chloro-thiophen-2-yl)-oxo-acetic acid ethyl ester；Ethyl 5-chlorothiophene-2-glyoxylate；ethyl 2-(5-chlorothiophen-2-yl)-2-oxoacetate
• CAS: 34036-28-7
• 化学式: C₈H₇ClO₃S
• 分子量: 218.661
• InChiKey: SAPAEGDTYVIFCE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  71.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  乙基(5-氯-2-噻吩基)(氧代)乙酸酯 在 吡啶 、 盐酸羟胺 、 水 、 碳酸氢钠 、 caesium carbonate 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 potassium hydroxide 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 甲醇 、 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 生成
  参考文献：
  名称：

  Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii

  摘要：

  The preparation and characterization of a series of thiophenyl oxime phosphonate beta-lactamase inhibitors is described. A number of these analogs were potent and selective inhibitors of class C beta-lactamases from Pseudomonas aeruginosa and Enterobacter cloacae. Compounds 3b and 7 reduced the MIC of imipenem against an AmpC expressing strain of imipenem-resistant P. aeruginosa. A number of the title compounds retained micromolar potency against the class D OXA-40 beta-lactamase from Acinetobacter baumannii and at high concentrations compound 3b was shown to reduce the MIC of imipenem against a highly imipenem-resistant strain of A. baumanii expressing the OXA-40 beta-lactamase. In mice compound 3b exhibited phamacokinetics similar to imipenem. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.04.122
• 作为产物：
  描述：

  2-氯噻吩 、 草酰氯单乙酯 在 三氯化铝 作用下， 以 硝基甲烷 为溶剂， 以71%的产率得到乙基(5-氯-2-噻吩基)(氧代)乙酸酯
  参考文献：
  名称：

  取代的噻吩基乙醇酸顺式-3,3,5-三甲基环己酯取代的顺式-3,3,5-三甲基环己基乙醇酸

  摘要：

  将生物等排原理应用于药物环兰地酯（Spasmocyclon®、Natil®）导致了异类酯的产生；两种化合物的药理学测试，如环地平，是非对映异构体的混合物，显示出微弱的钙拮抗作用 1)。

  DOI：

  10.1002/ardp.19893221115

文献信息

• Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as potent aldose reductase inhibitors.
  作者：TAKASHI SOHDA、KATSUTOSHI MIZUNO、EIKO IMAMIYA、HIROYUKI TAWADA、KANJI MEGURO、YUTAKA KAWAMATSU、YUJIRO YAMAMOTO

  DOI：10.1248/cpb.30.3601

  日期：——

  Thiazolidine-2, 4-dione derivatives having one or two substituent (s) such as phenyl, heteryl and alkyl group (s) at the 5-position were synthesized and evaluated as aldose reductase inhibitors. Inhibition by the active compounds of the swelling of the lens in a rat-lens-culture assay was also measured. Among these compounds, a series of 5-(3, 4-dialkoxyphenyl) thiazolidine-2, 4-diones showed pronounced activities in both assays. Structure-activity relationships are discussed and a new approach to the synthesis of 5-arylthiazolidine-2, 4-diones is described.

  具有一个或两个取代基（如苯基、杂基和烷基）的噻唑烷-2,4-二酮衍生物在5位合成并评估为醛糖还原酶抑制剂。在鼠晶状体培养检测中，活性化合物的抑制作用也被测量。在这些化合物中，一系列5-(3,4-二烷氧基苯基)噻唑烷-2,4-二酮在两种检测中显示出显著的活性。结构-活性关系进行了讨论，并描述了一种合成5-芳基噻唑烷-2,4-二酮的新方法。
• Synthesis of New Pyridazinone Derivatives: 2,6-Disubstituted 5-Hydroxy-3(2<i>H</i>)-pyridazinone-4-carboxylic Acid Ethyl Esters
  作者：Yuefen Zhou、Lian-Sheng Li、Jingjing Zhao、Peter Dragovich、Nebojsa Stankovic、Thomas Bertolini、Douglas Murphy、Zhongxiang Sun、Chinh Tran、Benjamin Ayida、Frank Ruebsam、Stephen Webber

  DOI：10.1055/s-2007-990823

  日期：2007.11

  2,6-Disubstituted 5-hydroxy-3(2H)-pyridazinone-4-carboxylic acid ethyl esters were synthesized from α-keto esters via an efficient three-step sequence including hydrazone formation, acylation with ethyl malonyl chloride, and subsequent Dieckmann cyclization.

  合成了2,6-二取代的5-羟基-3(2H)-吡嗪酮-4-羧酸乙基酯，过程采用了一种高效的三步法，包括肼酮的形成、与乙基美克氯的酰化和随后进行的迪克曼环化。
• Thiophenyl triazol-3-one derivatives as smooth muscle relaxants
  申请人：——

  公开号：US20030144333A1

  公开（公告）日：2003-07-31

  The present invention provides novel [1,2,4]triazole-3-one derivatives having the general formula (I) 1 wherein: Q is 2 and R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined herein or a nontoxic pharmaceutically acceptable salt or solvate thereof which are smooth muscle relaxants and useful in treating disorders responsive to relaxation of smooth muscle such as asthma, irritable bowel syndrome, male erectile dysfunction and urinary incontinence.

  本发明提供了具有一般式(I)1的新型[1,2,4]三唑-3-酮衍生物，其中：Q为2，R1、R2、R3、R4、R5和R6如本文所定义，或其非毒性药学上可接受的盐或溶剂，它们是平滑肌松弛剂，可用于治疗对平滑肌松弛有反应的疾病，如哮喘、肠易激综合征、男性勃起功能障碍和尿失禁。
• UNTERHALT, BERNARD;GERES, PETER, ARCH. PHARM., 322,(1989) N1, C. 839-840
  作者：UNTERHALT, BERNARD、GERES, PETER

  DOI：——

  日期：——
• CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE
  申请人：BioMarin Pharmaceutical Inc.

  公开号：US20190322676A1

  公开（公告）日：2019-10-24

  Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.